Vaccitech is a spinout company from the University of Oxford’s Jenner Institute, one of the oldest and most renowned vaccine research centers in the world.
You probably haven’t heard of them, but they are now working alongside AstraZeneca on a COVID-19 vaccine the World Health Organization believes is leading the race in creating an inoculation against SARS-CoV-02.
Data posted this month from just over 1,000 patients in a phase 1/2 trial showed it to be broadly effective in creating an immune response, though many questions remain and a series of bigger, late-stage tests is necessary to find those answers out.
Image: Bill Enright, Vaccitech CEO (Vaccitech)
{iframe}https://www.fiercebiotech.com/biotech/conversation-bill-enright-vaccitech-ceo-pandemic-vaccines{/iframe}